Teva Receives FDA Approval for Generic Differin

6 June 2010 (Last Updated June 6th, 2010 18:30)

Teva Pharmaceutical Industries has received US Food and Drug Administration approval for its generic version of Galderma's Differin Gel. Following the approval, Teva has announced the commercial launch of the product, which is used in the treatment of acne. According to IMS sa

Teva Pharmaceutical Industries has received US Food and Drug Administration approval for its generic version of Galderma's Differin Gel.

Following the approval, Teva has announced the commercial launch of the product, which is used in the treatment of acne.

According to IMS sales data, Differin has achieved annual sales of about $91m in the US.